BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7267481)

  • 1. Lithium toxicity induced by triamterene-hydrochlorothiazide.
    Mehta BR; Robinson BH
    Postgrad Med J; 1980 Nov; 56(661):783-4. PubMed ID: 7267481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrochlorothiazide/triamterene combination: once daily in the treatment of hypertension.
    Zacharias FJ; Cornhill J
    Br J Clin Pract; 1984 May; 38(5):185-7. PubMed ID: 6733013
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of mild-to-moderate hypertension: comparison between a calcium-channel blocker and a potassium-sparing diuretic.
    Boulet AP; Chockalingam A; Fodor JG; Laplante L; Houde M; Lenis J; Logan AG; Robitaille MN; Ryan D; Spénard J
    J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S45-50. PubMed ID: 1725543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Triamterene in the treatment of hypertension with hydrochlorothiazide and propranolol (author's transl)].
    Düsing R; Kramer HJ
    Dtsch Med Wochenschr; 1977 Oct; 102(43):1541-6. PubMed ID: 913294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy and bioequivalence of a brand-name and a generic triamterene-hydrochlorothiazide combination product.
    Sharoky M; Perkal M; Tabatznik B; Cane RC; Costello K; Goodwin P
    Clin Pharm; 1989 Jul; 8(7):496-500. PubMed ID: 2752698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term metabolic effects of spironolactone and thiazides combined with potassium-sparing agents for treatment of essential hypertension.
    Jeunemaitre X; Charru A; Chatellier G; Degoulet P; Julien J; Plouin PF; Corvol P; Ménard J
    Am J Cardiol; 1988 Nov; 62(16):1072-7. PubMed ID: 3189169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of plasma sodium levels in elderly people taking amiloride or triamterene in combination with hydrochlorothiazide.
    Fidler HM; Goldman J; Bielawska CA; Rai GS; Hoffbrand BI
    Postgrad Med J; 1993 Oct; 69(816):797-9. PubMed ID: 8290411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triamterene nephrolithiasis complicating dyazide therapy.
    Patel KM
    J Urol; 1981 Aug; 126(2):230. PubMed ID: 7265370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of a hydrochlorothiazide plus triamterene combination (Dyazide) and atenolol in the treatment of patients with mild hypertension: a multicentre study in general practice.
    Philip IG; Qureshi SM; Richards HH; Sharma SK; Wright FG; Young PH; Rowley-Jones D
    Br J Clin Pract; 1987 Oct; 41(10):947-53. PubMed ID: 3333144
    [No Abstract]   [Full Text] [Related]  

  • 10. Double-blind comparison of triamterene plus hydrochlorothiazide and spironolactone plus hydrochlorothiazide in the treatment of hypertension.
    Cocke TB; Fisch S; Gilmore HR; Okun R; Tamagna IG; Wipplinger K
    J Clin Pharmacol; 1977; 17(5-6):334-8. PubMed ID: 323298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with a new combination formulation of triamterene and hydrochlorothiazide (Maxzide) in patients with mild to moderate hypertension.
    Williams RL; Clark T; Blume CD
    Am J Med; 1984 Nov; 77(5A):62-6. PubMed ID: 6388328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive action of drug combination: Timolol, hydralazine, hydrochlorothiazide and triamterene.
    Pörsti P; Jalonen K; Ryysy L; Toivonen T; Viherkoski M
    Ann Clin Res; 1981 Feb; 13(1):6-10. PubMed ID: 7018363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Captopril versus hydrochlorothiazide/triamterene in mild-to-moderate hypertension in the elderly.
    Woo J; Woo KS; Vallance-Owen J
    Lancet; 1986 Oct; 2(8512):924. PubMed ID: 2876357
    [No Abstract]   [Full Text] [Related]  

  • 14. A single-blind, randomized, cross-over study of angiotensin-converting enzyme inhibitor and triamterene and hydrochlorothiazide in the treatment of mild to moderate hypertension in the elderly.
    Woo J; Woo KS; Kin T; Vallance-Owen J
    Arch Intern Med; 1987 Aug; 147(8):1386-9. PubMed ID: 2820329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive therapy with triamterene-hydrochlorothiazide vs amiloride-hydrochlorothiazide. Comparison of effects on urinary prostaglandin E2 excretion.
    Zawada ET
    Arch Intern Med; 1986 Jul; 146(7):1312-4. PubMed ID: 3521523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of triamterene on plasma and extracellular fluid volume and blood pressure in ten thiazide-treated hypokalemic patients with essential hypertension.
    Leth A; Ibsen H; Sederberg-Olsen P
    Scand J Clin Lab Invest; 1972 Dec; 30(4):437-40. PubMed ID: 4639649
    [No Abstract]   [Full Text] [Related]  

  • 17. A new antihypertensive agent: Maxzide (75 mg triamterene/50 mg hydrochlorothiazide).
    Blume CD; Williams RL
    Am J Med; 1984 Nov; 77(5A):52-8. PubMed ID: 6388327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triamterene-thiazide combination: alternative therapy for primary aldosteronism.
    Ganguly A; Weinberger MH
    Clin Pharmacol Ther; 1981 Aug; 30(2):246-50. PubMed ID: 7018790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group.
    McClennen W; Wilson T
    Clin Invest Med; 1998 Jun; 21(3):142-50. PubMed ID: 9627768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmarketing surveillance in 70,898 patients treated with a triamterene/hydrochlorothiazide combination (Maxzide).
    Hollenberg NK; Mickiewicz CW
    Am J Cardiol; 1989 Jan; 63(4):37B-41B. PubMed ID: 2911994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.